Singapore-Based A SPAC I Acquisition Prices US$60 Million IPO

Special purpose acquisition company A SPAC I Acquisition Corp. started trading on the Nasdaq Capital Market today. The firm aims to raise US$60.0 million in its initial public offering.

The offering consisted of 6.0 million company units at US$10.00 per unit. Each unit contains one Class A common share, three-fourths of a redeemable warrant, and one-tenth of a right. Each whole warrant is exercisable for one common share at US$11.50 per share while each whole right equates to one common share upon business combination. The shares, warrants, and rights, once trading separately, will be trading under “ASCA”, “ASCAW”, and “ASCAR”, respectively.

Chardan acts as the sole bookrunner for the said offering. The underwriters were granted a 45-day overallotment option to purchase additional 0.9 million units at the same IPO price.

The offering is expected to close on February 17, 2022, subject to customary closing conditions.

The Singapore-based blank check firm intends to focus on completing a business combination in the technology, media, and telecom (TMT) sector.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Isn’t In A Bubble, Currency Is. – Doug Casey

The Real Move Begins When They Cut Rates | Peter Krauth

Is Altamira Gold Sitting On Brazil’s Next Big Gold Discovery?

Recommended

Stifel Initiates Coverage On Goliath Resources With $5.00 Price Target

ESGold Completes Mill Building Construction, Final Equipment Procurement Underway

Related News

Tech SPAC Yotta Acquisition Prices US$100 Million IPO

Special purpose acquisition company Yotta Acquisition Corporation (Nasdaq: YOTAU) started trading its securities on the...

Wednesday, April 20, 2022, 02:23:00 PM

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM

Robinhood’s IPO to be Priced at $38 Per Share

Robinhood’s IPO is expected to hit the Nasdaq today, but it appears that unenthusiastic demand...

Thursday, July 29, 2021, 09:00:00 AM

Biotech Firm HilleVax Prices US$200 Million IPO

Biopharmaceutical company HilleVax, Inc. (Nasdaq: HLVX) began trading on the Nasdaq Global Select Market on...

Monday, May 2, 2022, 02:25:00 PM

New York-Based Bank Hanover Bancorp Prices US$26.8 Million IPO

New-York headquartered bank conglomerate Hanover Bancorp, Inc. (Nasdaq: HNVR) began trading on the Nasdaq Global...

Thursday, May 12, 2022, 02:24:00 PM